WARREN, N.J.----In patients with diabetes, the CYPHER® Sirolimus-eluting Coronary Stent outperformed the Taxus® Stent with significantly lower rates of in-segment restenosis , target lesion revascularization and major...
From the Department of Critical Care Medicine (EBM, AK, MTR, TTD, GC, DCA), CRISMA Laboratory (Clinical Research, Investigation, and Systems Modeling of Acute Illness), University of Pittsburgh, Pittsburgh, PA; Cordis...
There are four types of innovation that companies should consider for pursuit. Some are more attractive than others depending on whether the company is a start-up or an existing firm and whether it is competing in a growing or...
Research and Markets has announced the addition of the "United Kingdom Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012" report to their offering. This report is an essential source for in-depth...
JERUSALEM--(BUSINESS WIRE)--Gamida Cell Ltd. announced today a collaboration agreement with Biologics Delivery Systems Group, Cordis Corporation. Under the terms of the agreement, Biologics Delivery Systems will supply...
Research and Markets (http://www.researchandmarkets.com/research/9cbe1a/australia_cardiova) has announced the addition of the "Australia Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012" report to...
LONDON, UNITED KINGDOM--(Marketwire - July 2, 2008) - Reportlinker.com announces that a new market research report related to the Cardiovascular diseases industry is available in its catalogue. World Cardiovascular Catheters...
Research and Markets (http://www.researchandmarkets.com/research/1094ab/canada_cardiovascu) has announced the addition of the "Canada Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012" report to...
NewTek, Inc., manufacturer of industry-leading 3D animation and video products today announced the release of LightWave Rendition ?¢ for Adobe® Photoshop® CS3 Extended. Based upon the rendering engine of Emmy® Award-winning...